NEWS
PAVmed Subsidiary, Veris Health, Awarded $1.8 Million NIH Grant to Enhance Cancer Care
PAVmed's subsidiary, Veris Health, has been awarded a $1.8 million grant from the National Institute on Minority Health and Health Disparities (NIMHD), part of the National Institutes of Health (NIH). The two-year grant will fund research to optimize and validate the Veris Cancer Care Platform for medically underserved cancer patients, in partnership with an academic cancer center.
The research project, titled 'Bridging the Gap: Enhancing Cancer Care for Underserved Populations with the Veris Health Cancer Care Platform,' will focus on patients facing language barriers, access to technology, and socioeconomic disparities. This non-dilutive funding comes at a important time for Veris as it pursues financing to advance its commercial strategy, including regulatory clearance and launch of its implantable physiological monitor.
PAVmed's subsidiary, Veris Health, has been awarded a $1.8 million grant from the National Institute on Minority Health and Health Disparities (NIMHD), part of the National Institutes of Health (NIH). The two-year grant will fund research to optimize and validate the Veris Cancer Care Platform for medically underserved cancer patients, in partnership with an academic cancer center.
The research project, titled 'Bridging the Gap: Enhancing Cancer Care for Underserved Populations with the Veris Health Cancer Care Platform,' will focus on patients facing language barriers, access to technology, and socioeconomic disparities. This non-dilutive funding comes at a important time for Veris as it pursues financing to advance its commercial strategy, including regulatory clearance and launch of its implantable physiological monitor.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Spread kindness and love. Life is short. Don’t let greed eat you.
1778Followers
98Following
14KVisitors
Follow